Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ITA6 | P23229 | Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)] | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| ITAM | P11215 | Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b) | Cancer-related genesCD markersDisease related genes | 1 | Pancreatic cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| ITAV | P06756 | Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain] | Cancer-related genesCD markersFDA approved drug targets | 1 | Colorectal cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| LRP2 | P98164 | Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) | Disease related genesHuman disease related genesMetabolic proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 1 | 0.25 | |||
| LRP4 | O75096 | Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) | Disease related genesHuman disease related genesPotential drug targets | 1 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | |||
| LRP5 | O75197 | Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Solid tumour/cancer | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.25 | ||
| LYAM1 | P14151 | L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1) (LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1) (LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | AsthmaCirculatory system diseaseInfluenza | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| LYAM3 | P16109 | P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Allergic/hypersensitivity disorderArterial occlusive diseaseAsthma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| MINP1 | Q9UNW1 | Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) | Disease related genesEnzymesHuman disease related genes | Metabolism mediation | 1 | 0.25 | ||||
| MYP0 | P25189 | Myelin protein P0 (Myelin peripheral protein) (MPP) (Myelin protein zero) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Adhesion and uptake mediation | 1 | 0.25 | |||
| NEUR1 | Q99519 | Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1) | Disease related genesEnzymesFDA approved drug targets | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||||
| NFASC | O94856 | Neurofascin | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| NTRK1 | P04629 | High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) | Cancer-related genesDisease related genesEnzymes | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| PAR1 | P25116 | Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor) | FDA approved drug targetsG-protein coupled receptorsPredicted intracellular proteins | 7 | Arterial occlusive diseaseArteries/arterioles disorderChronic arterial occlusive disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| PDCD1 | Q15116 | Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279) | CD markersDisease related genesFDA approved drug targets | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | |||
| PE2R3 | P43115 | Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaChronic arterial occlusive diseaseGlaucoma | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.25 | ||
| PGFRB | P09619 | Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) | Cancer-related genesCD markersDisease related genes | 1 | Acute diabete complicationAlzheimer diseaseGram-positive bacterial infection | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| PLXA1 | Q9UIW2 | Plexin-A1 (Semaphorin receptor NOV) | Disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.25 | |||
| PLXD1 | Q9Y4D7 | Plexin-D1 | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.25 | |||
| PTC1 | Q13635 | Protein patched homolog 1 (PTC) (PTC1) | Cancer-related genesDisease related genesHuman disease related genes | 12 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.25 | |||
| PTPRC | P08575 | Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45) | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaDiffuse large B-cell lymphomaLeukaemia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| S12A5 | Q9H2X9 | Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter) | Disease related genesFDA approved drug targetsHuman disease related genes | 12 | Epilepsy/seizure | Clinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| S1PR1 | P21453 | Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363) | Cancer-related genesCD markersFDA approved drug targets | 7 | Acne vulgarisCardiovascular diseaseCrohn disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| S1PR5 | Q9H228 | Sphingosine 1-phosphate receptor 5 (S1P receptor 5) (S1P5) (Endothelial differentiation G-protein-coupled receptor 8) (Sphingosine 1-phosphate receptor Edg-8) (S1P receptor Edg-8) | FDA approved drug targetsG-protein coupled receptorsPredicted intracellular proteins | 7 | Multiple sclerosis | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.25 | ||
| S22A4 | Q9H015 | Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (ETTh) (Organic cation/carnitine transporter 1) (OCTN1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.25 |